Professor Cherrie Galletly

Professor Cherrie Galletly
 Position Interim Dean
 Org Unit Medical Specialties
 Email cherrie.galletly@adelaide.edu.au
 Telephone +61 8 8269 8144
 Location 33 Park Terrace-Gilberton SA 5081 ,   The Adelaide Clinic
  • Biography/ Background

    Professor Cherrie Galletly is a consultant psychiatrist working across the University, public mental health and private sectors. She takes a collaborative approach to research, with the ultimate goal of improving the quality of care for people with severe mental illness. Her research interests include schizophrenia and other psychotic disorders; she was Northern Adelaide site director for the Second National Survey of Psychosis (2010) a landmark study of more than 1800 people with psychoses. She heads up one of the leading national centres on neurostimulation treatments for psychiatric disorders. Her teaching responsibilities include the role of Course Convenor for Year 6 MBBS. She has 3 current and 6 completed PhD higher students. She is a Regional Director of postgraduate psychiatry training (Northern Area Local Health Network).

     

    She led the writing of the RANZCP Clinical Practise Guidelines for Schizophrenia and Related Disorders. She is an Associate Editor for the Australian and New Zealand Journal of Psychiatry and a member of the Editorial Executive for Australian Prescriber.She is a member of the NHMRC Mental Health Research Advisory Committee (2018).

     

    She has published more than 200 papers in the peer reviewed literature, one book and 3 book chapters, and over 50 other articles and abstracts. Her total collaborative research funding exceeds $7m.

     

    Current Positions

     

    Professor of Psychiatry –Acting Head of Discipline of Psychiatry. Chair jointly funded by University of Adelaide and Ramsay Health Care (SA) Mental Health.

     

    Regional Director of Training, Northern Adelaide Local Health Network

  • Qualifications

    2003 Doctor of Philosophy (PhD), Flinders University, South Australia

    1984 Fellow, Royal Australian and New Zealand College of Psychiatrists

    1981 Member, Royal Australian and New Zealand College of Psychiatrists

    1980 Diploma in Psychological Medicine (DPM), University of Otago, New Zealand

    1975 Bachelor of Medicine and Surgery (MBChB), University of Otago, New Zealand

  • Teaching Interests

    Teaching

    Undergraduate

    Course Advisor Year 6 MBBS

    Higher Degree 
    3 current PhD students

    Completions: 6 PhD, 6 Masters, 5 Honours students

     

    Postgraduate
    Regional Director of Training (RANZCP training program), Northern Adelaide Local Health Network

    Member of SA Branch Psychiatry Training Committee

  • Research Interests

    Current Research Projects

    Second National Survey of Psychosis (2010): This federally funded study involved 8 sites; Professor Galletly was involved in the planning and execution of this major national project. She is participating in the analysis and dissemination of this data, including a local 5 year follow-up study. She heads the cardiometabolic writing group and supervises three PhD students working on this project.

     

    Stopping the run-around: comorbidity action in the north: This study is funded by an ARC Partnership Grant and uses participatory action methods to investigate services for people with comorbid and alcohol and mental health disorders. Two PhD students are researching the Aboriginal and Refugee aspects of this project.

     

    Childhood cognitive antecedents of adult psychopathology: follow up of the Port Pirie lead cohort into adulthood: NHMRC funded study, data collection of this cohort 25 years after the original study has been completed.

     

    The Cognitive and Affective Symptoms of Schizophrenia Intervention (CASSI) Trial: double-blind cross-over trial of raloxifene in people with schizophrenia; investigates the genetic and clinical aspects of the use of oestrogen receptor modulators in schizophrenia.

     

    Telomere erosion in schizophrenia: examining lifestyle factors, oxidative stress and telomere length in people with schizophrenia.

     

    Sleep disorders in schizophrenia: uses home sleep studies to investigate the nature, prevalence and treatment of sleep disorders in people with schizophrenia.

    Metacognitive treatment for delusions in people with schizophrenia: uses cognitive therapies to address the cognitive biases that underlie delusional beliefs.

     

    Health literacy in people with mental illness: a comparison of health literacy in people with mental illness in the USA and Australia: builds on previous local health literacy research.

     

    Medication compliance in people with schizophrenia: utilises qualitative research methods to investigate the reasons people with schizophrenia stop their medication.

     

    Neurostimulation Research Group: multiple projects on ECT and rTMS, based in the private sector.

  • Research Funding

    NHMRC Grants

    National Health and Medical Research Council (NHRMC), Australia: 1098442; Castle, D., Rossell, S., Galletly, C., Harris, A., Francies, P., Siskind, D.; Project Grant; Title: “N-Acetyl Cysteine In Schizophrenia Resistant to Clozapine: A Double-Blind Randomised Placebo-Controlled Trial”; Funds: $981,788.85; 2016-2019.

    National Health and Medical Research Council (NHRMC), Australia: 1102628; Morgan, V., McGrath, J., Galletly, C., Harvey, C., Castle, D., Cohen, M., Jablensky, A., Carr, V., Neil, A., Wattereus, A.; Project Grant; Title: “An empirical framework for assessing mortality and morbidity in people with psychotic disorders: 7-year prospective and 10-year retrospective follow-up of 2075 participants in the Survey of High Impact Psychosis (SHIP) using linked registers”; Funds: $626,179; 2016-2020.

    ARC Linkage Grant (2011-2013) 

    Australian Research Council, Australia: LP110100087; de Crespigny CF, Galletly C, Athanasos P, Procter NG, Moss JR, Rowlands CE, Liu DT, Tyllis P, Chong AJ, Lee D; Linkage Grant; Title: “Stopping the run-around: comorbidity action in the north (CAN)” ; Funds : $275,820; 2011-2013.

    Grant Assessor

    Member of NHMRC Panels for Project Grants and Practitioner Fellowships

    Project Grant Assessor for NHMRC; member of Project Grants Peer Review Honour Roll

    ARC Grant Assessor - Linkage Projects, Early Career Research Awards

    Ontario Mental Health Foundation

    The Chief Scientist Office Project Grant Scheme, Scottish Government

  • Publications

    Publications in the Last 5 Years:

    Enticott, P. G, Barlow, K, Guastella, A. J, Licari, M. K, Rogasch, N. C, Middeldorp, C. M, Clark, S. R, Vallence, A, Boulton, K. A, Hickie, I. B, Whitehouse, A. J. O, Galletly, C, Alvares, G, Fujiyama, H, Heussler, H, Craig, J, Kirkovski, M, Mills, N. T, Rinehart, N. J, Donaldson, P. H, Ford, T. C, Caeyenberghs, K, Albein-Urios, N, Bekkali, S, & Fitzgerald, P. B. (In press). Repetitive transcranial magnetic stimulation (rTMS) in autism spectrum disorder: protocol for a multicentre randomised controlled clinical trial. BMJ Open.

    Giam, A, Chen, L, Hahn, L, Gill, S, Clarke, C, Ng, F, Galletly, C, Fitzgerald, P. (2021).Comparing theta burst stimulation with standard left high frequency transcranial magnetic stimulation in the treatment of depression in a randomized controlled study: A preliminary comparison study. Journal of Affective Disorder Reports, 5, 100162. 

    Nguyen, H, Haeney, O, Galletly, C. (2021). The Characteristics of Older Homicide Offenders: a Systematic Review. Psychiatry, Psychology and Law, 0, 1-18. 

    Galletly, C, Suetani, S, Hahn, L, McKellar, D, Castle, D. (2021). Ageing with psychosis – Fifty and beyond. ANZJP, 1-11. doi: 10.1177/00048674211009619.

    Ford, H, Hahn, L, Clarke, P, Gill, S, Carnell, B, Galletly, C. (2021). A comparison of 15 minute vs 30 minute repetitive transcranial magentic stimulation sessions for treatment resistant depression - are longer treatment sessions more effective? Journal of Affective Disorders, 282, 974-978. 

    Ji, E, Weickert, CS, Purves-Tyson, T, White, C, Handelsman, DJ, Desai, R, O'Donnell, M, Liu, D, Galletly, C, Lenroot, R, Weickert, TW. (2021). Cortisol-dehydroepiandrosterone ratios are inversely associated with hippocampal and prefrontal brain volume in schizophrenia. Psychoneuroendocrinology, 123, 104916. 

    Henderson, S, Berk, M, Boyce, P, Jorm, AF, Galletly, C, Porter, RJ, Mulder, RT, Malhi, GS. (2020). Finding reviewers: A crisis for journals and their authors. Australian and New Zealand Journal of Psychiatry, 54, 957-959. 

    Siskind, D, Northwood, K, Berk, M, Castle, D, Galletly, C. Harris, A. (2020). Monitoring for post-injection delirium/sedation syndrome with long-acting olanzapine during the COVID-19 pandemic. (letter). ANZJP, 54, 759-761. 

    Galletly, C. (2020). Sexual Misconduct by Doctors - a problem that hasn't gone away. The Medical Journal of Australia. doi: 10.5694/mja2.50734. 

    Thomson, S, Doan, T, Liu, D, Schubert, O, Toh, J, Haeney, O, Galletly, C. (2020). Supporting the Vulnerable: Developing a Strategic Community Mental Health Response to the COVID-19 Pandemic. Australasian Psychiatry. doi: 10.1177/1039856220944701. 

    Cai, H, Weickert, T, Catts, V, Balzan, R, Galletly, C, Liu, D, O'Donnell, M, Weickert, C. (2020). Altered levels of immune cell adhesion molecules are associated with memory impairment in schizophrenia. Brain Behav Immun, doi: 10.1016/j.bbi.2020.06.017.

    Clifford, L, Crabb, S, Turnbull, D, Hahn, L, Galletly, C. (2020). A Qualitative Study of Medication Adherence amongst People with Schizophrenia. Archives of Psychiatric Nursing, 34, 194-199. 

    Plevin, D, Galletly, C. (2020). The neuropsychiatric effects of vitmain C deficiency: a systematic review. BMC Psychiatry, 20:315. 

    Galletly, C. (2020). Psychiatry in the COVID-19 Era. ANZJP This Mont, 54, 447-448. 

    Zulfic, Z, Weickert, CS, Weickert, TW, Liu, D, Myles, N, Galletly, C. (2020). Neutrophil-lymphocyte ratio - a simple accessible measure of inflammation, morbidity and prognosis in psychiatric disorders? Australasian Psychiatry, 28, 254-258.

    Wong, KTG, Liu, D, Balzan, R, King, D, Galletly, C. (2020). Smartphone and Internet Access and Utilization by people with Schizophrenia in South Australia: Quantitative Survey Study. JMIR Mental Health, 7:e11551. 

    Turner, S, Harvey, C, Hayes, L, Castle, D, Galletly, C, Sweeney, S, Shah, S, Keogh, L, Spittal, MJ. (2019). Childhood adveristy and clinical and psychosocial outcomes in psychosis. Epidemiology and Psychiatric Sciences, 16:29:e78. 

    Lee, CH, Sinclair, D, O'Donnell, M, Galletly, C, Liu, D, Weickert, CS, Weickert, TW. (2019). Transcriptional chnages in the stress pathway are related to symptoms in schizophrenia and to mood in schizoaffective disorder. Schizophrenia Research, 213, 87-95. 

    Galletly, C. (2019). More access for some but not others: is it better? Aust N Z J Psychiatry, 53, 1041-1043. 

    Firth, J, Rosenbaum, S, Galletly, C, Siddiqi, N, Stubbs, B, Killackey, E, Koyanagi, A, Siskind, D. (2019). Protecting physical health in people with mental illness - Author's Reply. Lancet Psychiatry, 6, 890-891. 

    Firth, J, Siddiqi, N, Koyanagi, A, Siskind, D, Rosenbaum, S, Galletly, C, Allan, C, Caneo, C, Carney, R, Carvalho, AF, Chatterton, ML, Correll, CU, Curtis, J, Gaughran, F, Heald, A, Hoare, E, Jackson, SE, Kisely, S, Lovell, K, Maj, M, McGorry, PD, Mihalopoulos, C, Myles, H, O'Donoghue, B, Pillinger, T, Sarris, J, Schuch, FB, Shiers, D, Smith, L, Solmi, M, Suetani, S, Taylor, J, Teasdale, SB, Thornicroft, G, Torous, J, Usherwood, T, Vancampfort, D, Veronese, N, Ward, PB, Yung, AR, Killackey, E, Stubbs, B. (2019). The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. Lancet Psychiatry, 6, 675-712. 

    Galletly, CA, Ash, D, Sweeney, S, O'Neil, Chrichton, J. (2019). Identifying and exploring linguistic expertise of psychiatrists in interviews with patients with thought disorder. Australasian Psychiatry, 

    Clarke, E, Clarke, P, Gill, S, Paterson, T, Hahn, L, Galletly, C. (2019). Efficacy of repeitive transcranial magnetic stimulation in the treatment of depression with comorbid anxiety disorders. Journal of Affective Disorders, 252, 435-439. 

    Owens, SJ, Weickert, WT, Purves-Tyson, T, Ji, E, White, C, Galletly, C, Liu, D, O'donnell, M, Weickert, S,C. (2019). Sex-Specific Associations of Androgen Receptor CAG Trinucleotide Repeat Length and of Raloxifene Treatment with Testosterone Levels and Perceived Stress in Schizophrenia. Molecular Neuropsychiatry, 5, 28-41. 

    Galletly, C. (2019). Paracetamol, pregnancy and public health. Australian and New Zealand Journal of Psychiatry, 53, 181-183. 

    Lim, X, Galletly, C. (2019). "To suit the occasion, I wore my schizophrenic fancy dress"- The life of Janet Frame. Australasian Psychiatry, 5, 469-471. 

    Szabo, S, Lloyd, B, McKellar, D, Myles, H, Newton, H, Schutz, J, Hahn, L, Galletly, C. (2019). 'Having a mentor helped me with difficult times: a trainee-run mentoring project. Australasian Psychiatry, 1-4. 

    Balzan, R, P, Mattiske, J, K, Delfabbro, P, Liu, D, Galletly, C. (2019). Individualized Metacognitive Training (MCT+) Reduces Delusional Symptoms in Psychosis. A Randomised Clinical Trial. Schizophrenia Bulletin, 45, 27-36. 

    Myles, H, Myles, N, Coetzer, CLC, Adams, R, Chandratilleke, M, Liu, D, Mercer, J, Vakulin, A, Vincent, A, Wittert, G, Galletly, C. (2019). Cognition in schizophrenia improves with treatment of severe obstructive sleep apnoea. A pilot study: Schizophrenia Research Cognition, 15, 14-20. 

    Wong, GTK, King, D, Balzan, R, Liu, D, Galletly, C. (2018). Technology Literacy and engagement in people with schizophrenia. Schizophrenia Bulletin, 44S208-S208.

    Galletly, C, Myles, M. (2018). Making an Impact. Australian and New Zealand Journal of Psychiatry, 52, 225-726. 

     Jacomb, I, Stanton, C, Vasudevan, R, Powell, H, O'Donnell, M, Lenroot, R, Bruggemann, J, Balzan, R, Galletly, C, Liu, D, Weickert, CS, Weickert TW. (2018). C-Reactive Protein: Higher during acute psychotic episodes and related to cortical thickness in schizophrenia and healthy controls. Frontiers in Immunology, 9, 1-16.

    Rosenich, E, Gill, S, Clarke, P, Paterson, T, Hahn, L, Galletly, C. (2018). Does rTMS reduce depressive symptoms in young people who have not responded to antidepressants? Early Intervention in Psychiatry. doi: 1111/eip.12743.

    Weickert, C, Cai, H, Catts, V, Webster, M, Galletly, C, Liu, D, O'Donnell, M, Weickert, T. (2018). Increased macrophages and brain endothelial cell gene expression changes in the frontal cortex of people with schizophrenia displaying inflammation. Molecular Psychiatry. doi: 10.1038/s41380-018-1235-x.

    Galletly, C, Suetani, S, Dark, F. (2018). Medication discontinuation clinics for people with psychosis: Thinking about the offset of psychotic disorders. Australian and New Zealand Journal of Psychiatry, 52, 819-821.

    Yolland, COB, Pjillipou, A, Castle, DJ, Neill, E, Hughes, ME, Galletly, C, Smith, ZM, Francis, PS, Dean, OM, Sarris, J, Siskind, D, Harris, AWF, Rossell, SL. (2018). Improvement of Cognitive Function in Schizophrenia with N-Acetylcysteine: A Theoretical Review. Nutritional Neuroscience, 30, 1-10.

    Myles, H, Vincent, A, Myles, N, Adams, R, Chandratilleke, M, Liu, D, Mercer, J, Vakulin, J, Wittert, G, Galletly, C. (2018). Obstructive sleep apnoea is more prevalent in men with schizophrenia compared to general population controls: results of a matched cohort study. Australasian Psychiatry, 26, 600-603.

    Myles, N, Myles, H, Xia, S, Large, M, Kisley, S, Galletly, C, Bird, R, Siskind, D. (2018). Meta-analysis examining the epidemiology of clozapine-associated neutropenia. Acta Psychiatrica, doi: 10.1111/acps.12898.

    Haeney, O, Ash, D, Galletly, C. (2018). School Shootings - 'It wouldn't happen here?' Australian and New Zealand Journal of Psychiatry, 52, 405-407.

    Foley, DL, Mackinnon, A, Morgan, VA, Castle, DJ, Waterreus, A, Galletly, CA. (2018). Comorbid Diabetes and Depression in a National Sample of Adults with Psychosis. Schizophr Bull, 44, 84-92.

    Campbell, LE, Hanlon, MC, Galletly, CA, Harvey, C, Stain, H, Cohen, M, van Ravenzwaaij, D, Brown, S. (2017). Severity of illness and adaptive functioning predict quality of care of children among parents with psychosis: A confirmatory factor analysis. Australian and New Zealand Journal of Psychiatry, 52, 435-445.

    Koblar, S, Cranwell, M, Koblar, S, Carnell, B, Galletly, C.  (2017). Developing empathy: does experience through simulation improve medical student empathy? Medical Science Educator, 28, 31-36.

    Boerrigter, D, Weickert, TW, Lenroot, R, O'Donnell, M, Galletly, C, Liu, D, Burgess, M, Cadiz, R, Jacomb, I, Catts, VS, Fillman, SG, Weickert, CS. (2017). Using Blood Cytokine Measures to Define High Inflammatory Biotype of Schizophrenia and Schizoaffective Disorder. Journal of Neuroinflammation, 14:188.

    Glass, LJ, Sinclair, D, Boerrigter, D, Naude K, Fung, SJ, Brown, D, Catts, VS, Tooney, P, O'Donnell, M, Lenroot, R, Galletly, C, Liu, D, Weickert TW, Weickert, CS. (2017). Brain antibodies in the cortex and blood of people with schizophrenia and controls. Transl Psychiatry, 7:e1192.

    Jablensky, A, Castle, DJ, Dark, F, Humberston, V, Killackey, E, Kulkarni, J, McGorry, P, Morgan, V, Nielssen, O, Tran, N, Galletly, C. (2017). The 2016 RANZCP Guidelines for the management of Schizophrenia and Related Disorders - what's next? Australasian Psychiatry, 25, 600-602.

    Castle, DJ, Galletly, CA, Dark, F, Humberstone, V, Morgan VA, Killackey, E, Kulkarni, J, McGorry, P, Nielssen, O, Tran, NT, Jablensky, A. (2017) The 2016 Royal Australian and New Zealand College of Psychiatrists guidelines for the management of schizophrenia and related disorders. MJA, 206(11): 501-505.

    Posselt, M, McDonald, K, Procter, N, de Crespigny, C, Galletly, C. (2017). Improving the provision of services to young people from refugee backgrounds with comorbid mental health and substance use problems: addressing the barriers. BMC Public Health, 17(1): 280.

    Nielssen, O, McGorry, P, Castle, D, Galletly, C. (2017). The RANZCP guidelines for Schizophrenia: Why is our practice so far short for our recommendations and what can we do about it? Australian and New Zealand Journal of Psychiatry, 51, 670-674.

    Galletly, C. (2017). Premature death in schizophrenia: bridging the gap. Lancet Psychiatry, 4, 263-265.

    Galletly, C, Dhillon, VS, Liu, D, Balzan, RP, Hahn, LA, Fenech, MF. (2017). Shorter telomere length in people with schizophrenia: a preliminary study from Australia. Schizophrenia Research, 190, 46-51.

    Carnell, BL, Clarke, P, Gill, S, Galletly, CA. (2017). How effective is repetitive Transcranial Magnetic Stimulation for Bipolar Depression? Journal of Affective Disorders, 209, 270-272.

    Galletly, C. (2017). Premature death in schizophrenia: bridging the gap. The Lancet Psychiatry, 4, 263-265.

    Allison, S, Bastiampillai, T, Galletly, C, Nance M. (2017). An Australian collaborative research network: Building the evidence for inpatient psychiatry. Australian and New Zealand Journal of Psychiatry, 51(8): 845.

    Myles, H, Myles, N, Liu, D, Adams, R, Wittert, G, Antic, NA, Galletly, C. (2017). How long will we sleep on obstructive sleep aponea in schizophrenia? Australian and New Zealand Journal of Psychiatry, 5, 95-96.

    Smith, C, Myles, H, Galletly, C. (2017). Developing a Metformin Prescribing Tool for Use in Adults with Mental Illness to Reduce Medication-Relate Weight Gain and Cardiovascular Risk. Australasian Psychiatry, 25, 387-390.

    Large, M, Galletly, C, Myles, N, Ryan, CJ, Myles, H. (2017). Known unknown and unknown unknowns in Suicide Risk Assessment: Aleatory and Epistemic uncertainty. BJ Psych Bulletin, 41, 160-163.

    Morgan, VA, Waterreus, A, Carr, V, Castle, D, Cohen, M, Harvey, C, Galletly, C, Mackinnon, A, McGorry Patrick, McGrath, JJ, Neil, AL, Saw, S, Badcock, JC, Foley, DL, Waghorn, G, Coker, S, Jablensky A. (2017). Responding to challenges for people with psychotic illness: Updated evidence from the Survey of High Impact Psychosis. Australian and New Zealand Journal of Psychiatry, 51, 124-140.

    Kulkarni, J & Galletly, C. (2017). Improving safety for women in psychiatry wards. Australian and New Zealand Journal of Psychiatry, 51, 192-194.

  • Professional Associations

    Australian Medical Association

     

    Australian and New Zealand Association of Psychiatry, Psychology and the Law

     

     

    Collegium Internationale Neuropsychopharmacologium

     

    European Association of Threat Assessment Professionals

     

    Royal Australian & New Zealand College of Psychiatrists

     

    RANZCP Section for Neurosciences

     

    Schizophrenia International Research Society

     

  • Media Expertise

    CategoriesMedicine & Medical Research, Psychology & Psychiatry
    ExpertiseMemory; Working memory (and its effects on schizophrenia); schizophrenia among young people; schizophrenia; youth; academic psychiatry; PTSD; professional boundaries; obesity; medicolegal
    After hours0406422494

The information in this directory is provided to support the academic, administrative and business activities of the University of Adelaide. To facilitate these activities, entries in the University Phone Directory are not limited to University employees. The use of information provided here for any other purpose, including the sending of unsolicited commercial material via email or any other electronic format, is strictly prohibited. The University reserves the right to recover all costs incurred in the event of breach of this policy.

Entry last updated: Sunday, 19 Sep 2021

To link to this page, please use the following URL:  https://www.adelaide.edu.au/directory/cherrie.galletly